M B Agro Prod. Q2 FY27 results are out (Jul–Sep 2026) →Revenue ₹715 Cr +58.9% YoYSee revenue, profit and what management said. You are viewing Q2 FY26.
MB

M B Agro Prod.

Q2 FY26Fertilizers & Agrochemicals

Madhya Bharat Agro Products Q2 FY26: Capex ₹400 Cr

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹450Cr
+61.9% YoY
+9.8% QoQ
Net profit
₹30Cr
+114.3% YoY
+7.1% QoQ
Margin
14%
+1 pp YoY
0 pp QoQ
Price₹170
Market cap₹7.4K Cr
P/E47.6

The short version

H2 FY '26 is expected to have revenue similar to H1 FY '26 (~₹860 crore), not at the same high growth rate but maintaining production capacity utilization. H1 FY26 PAT increased by 132% YoY to ₹59 crore, with EPS doubling to ₹6.7, reflecting strong profitability.

From M B Agro Prod.'s Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • H2 FY '26 is expected to have revenue similar to H1 FY '26 (~₹860 crore), not at the same high growth rate but maintaining production capacity utilization.
  • Total fertilizer production capacity will more than double to approximately 1.2 million tons by September 2026 due to expansions at Sagar (March ’26) and Dhule (September ’26).
  • Strong sales growth expected from NPK fertilizers, which contribute higher EBITDA per ton (~₹6,000) compared to SSP (~₹1,800).
  • SSP and NPK volumes sold in H1 FY '26 were 1,18,418 MT and 1,16,288 MT respectively, with strong demand projected to continue.
  • Post capacity expansions, strong performance and volume growth anticipated over the coming years.

2 more points from M B Agro Prod.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

H1 FY26 PAT increased by 132% YoY to ₹59 crore, with EPS doubling to ₹6.7, reflecting strong profitability.

Locked: what M B Agro Prod. said on margins

Also locked on this page: fundraising, order book

Free account, 30 seconds. No card needed.

Capital Expenditure Plans

  • Current CAPEX for FY '26: Approximately ₹400 crore, focusing on ongoing capacity expansions.
  • Total CAPEX for Sagar and Dhule projects: Around ₹700 crore in fixed assets; ₹200 crore already spent, ₹200 crore expected by March 2026, balance in first half of FY '27.
  • Funding: Combination of debt (around ₹430 crore in term loans with most sanctions in place) and internal accruals.
  • Expansion projects:
  • Sagar (Madhya Pradesh): Capacity expansion of 90,000 MTPA DAP/NPK and 1,65,000 MTPA sulfuric acid, to be commissioned by March 2026.

2 more points from M B Agro Prod.'s call on capex

Create a free account to keep reading this call

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company plans a total CAPEX of around ₹700 crore for Sagar and Dhule projects.

Locked: what M B Agro Prod. said on fundraising

Also locked on this page: margins, order book

Free account, 30 seconds. No card needed.

Order Book & Pipeline

See what M B Agro Prod. said on order book & pipeline — free account, 30 seconds.

M B Agro Prod. — Quarterly revenue & net profit

Revenue Net profit
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27

M B Agro Prod. Q2 FY26 results — key figures

M B Agro Prod. Q2 FY26 reported results vs year-ago quarter, ₹ crore
₹ CrQ2 FY26
Revenue450
Operating profit (EBITDA)62
Operating margin13.7%
Profit before tax49
Net profit (PAT)30
EPS (₹)3.48

Source: M B Agro Prod.'s results filing to NSE (standalone), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹416 Cr, net profit ₹33 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Bhagiradha Chemicals & Industries (Q2 FY26)

    140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran

  • Khaitan Chemical (Q2 FY26)

    Q2-FY26 Operational Revenue: INR 3,086 million, up 33.8% year-on-year (Q2-FY25: INR 2,306 million). Key investor presentation takeaways from Khaitan Chemical's

  • Rama Phosphates (Q2 FY26)

    Revenue from Operations for Q2 FY26: ₹24,566 Lacs . Key investor presentation takeaways from Rama Phosphates's Q2 FY26 investor presentation — and how it ranks

  • Krishana Phoschem (Q2 FY26)

    Trading contributes around 20%–22% of total turnover; trading volumes may vary depending on market conditions. Key concall takeaways from Krishana Phoschem…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

M B Agro Prod. and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were M B Agro Prod. Q2 FY26 results?

H2 FY '26 is expected to have revenue similar to H1 FY '26 (~₹860 crore), not at the same high growth rate but maintaining production capacity utilization. H1 FY26 PAT increased by 132% YoY to ₹59 crore, with EPS doubling to ₹6.7, reflecting strong profitability.

What is M B Agro Prod. share price analysis?

M B Agro Prod. currently shows a neutral. The stock trades at a P/E of 47.6 with a market cap of ₹7,381 Cr. Investors should review the full earnings analysis for detailed insights.

Is M B Agro Prod. planning capital expenditure?

Current CAPEX for FY '26: Approximately ₹400 crore, focusing on ongoing capacity expansions.

Keep M B Agro Prod. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.